Stryker ROA 2006-2018 | SYK

Current and historical return on assets (ROA) values for Stryker (SYK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Stryker ROA for the three months ending December 31, 2018 was 11.95%.
Stryker ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $3.55B $27.23B 15.28%
2018-09-30 $1.24B $22.08B 5.62%
2018-06-30 $1.08B $21.57B 4.94%
2018-03-31 $1.02B $22.13B 4.68%
2017-12-31 $1.02B $22.20B 4.77%
2017-09-30 $1.78B $21.49B 8.50%
2017-06-30 $1.70B $21.29B 8.25%
2017-03-31 $1.69B $20.52B 8.27%
2016-12-31 $1.65B $20.44B 8.15%
2016-09-30 $1.66B $20.19B 8.66%
2016-06-30 $1.61B $20.52B 8.88%
2016-03-31 $1.62B $19.67B 9.42%
2015-12-31 $1.44B $16.22B 8.78%
2015-09-30 $1.18B $15.92B 7.07%
2015-06-30 $0.93B $16.82B 5.47%
2015-03-31 $0.67B $16.58B 3.90%
2014-12-31 $0.52B $17.28B 3.02%
2014-09-30 $0.64B $17.52B 3.85%
2014-06-30 $0.69B $17.23B 4.29%
2014-03-31 $0.77B $16.16B 5.05%
2013-12-31 $1.01B $15.74B 6.81%
2013-09-30 $0.89B $14.88B 6.29%
2013-06-30 $1.14B $14.38B 8.37%
2013-03-31 $1.25B $14.09B 9.57%
2012-12-31 $1.30B $13.21B 10.24%
2012-09-30 $1.43B $12.78B 11.51%
2012-06-30 $1.40B $12.26B 11.46%
2012-03-31 $1.39B $12.46B 11.50%
2011-12-31 $1.35B $12.15B 11.43%
2011-09-30 $1.24B $12.08B 10.82%
2011-06-30 $1.25B $11.60B 11.23%
2011-03-31 $1.26B $11.23B 11.71%
2010-12-31 $1.27B $10.90B 12.17%
2010-09-30 $1.28B $10.77B 12.84%
2010-06-30 $1.18B $10.06B 12.48%
2010-03-31 $1.15B $10.10B 12.92%
2009-12-31 $1.11B $9.07B 13.40%
2009-09-30 $1.08B $8.46B 13.67%
2009-06-30 $1.12B $7.92B 14.65%
2009-03-31 $1.14B $7.59B 14.80%
2008-12-31 $1.15B $7.60B 14.85%
2008-09-30 $1.15B $7.58B 14.94%
2008-06-30 $1.10B $8.03B 14.70%
2008-03-31 $1.07B $7.75B 15.01%
2007-12-31 $1.02B $7.35B 15.25%
2007-09-30 $0.97B $6.86B 15.38%
2007-06-30 $0.93B $6.42B 15.63%
2007-03-31 $0.87B $6.08B 15.57%
2006-12-31 $0.78B $5.87B 14.56%
2006-09-30 $0.73B $5.40B 14.21%
2006-06-30 $0.66B $5.11B 13.56%
2006-03-31 $0.63B $4.99B 13.48%
2005-12-31 $0.64B $4.99B 14.61%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $72.140B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14